Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma
Clinical trial NCT06646588 · RECRUITING
Trial details
- NCT number
- NCT06646588
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2026-04-30
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.